Method for treating inflammatory bowel disease (IBD) by an anti-CD20 antibody

Details for Australian Patent Application No. 2006236816 (hide)

Owner Genentech, Inc.

Inventors Gujrathi, Sheila

Agent Griffith Hack

Pub. Number AU-A-2006236816

PCT Pub. Number WO2006/113308

Priority 60/671,902 15.04.05 US

Filing date 13 April 2006

Wipo publication date 26 October 2006

International Classifications

A61K 31/00 (2006.01)

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

18 October 2007 PCT application entered the National Phase

  PCT publication WO2006/113308 Priority application(s): WO2006/113308

25 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006236825-Low moisture polymer sheets for non autoclave process

2006236815-Processes for production and purificatio of normal propyl bromide